Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 18, Issue 10, pp. 1844-1851
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 11, 2019
- Revision received April 5, 2019
- Accepted July 25, 2019
- Published first July 30, 2019.
Article Versions
- Previous version (July 30, 2019 - 06:56).
- You are viewing the most recent version of this article.
Copyright & Usage
©2019 American Association for Cancer Research.
Author Information
- Milena Music1,
- Marco A.J. Iafolla2,
- Annie He Ren1,
- Antoninus Soosaipillai3,
- Ioannis Prassas3, and
- Eleftherios P. Diamandis1,3,4,5,*
- 1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.
- 2Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
- 3Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Canada.
- 4Department of Clinical Biochemistry, University Health Network, Toronto, Canada.
- 5Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, Canada.
- ↵*Corresponding Author:
Eleftherios P. Diamandis, Mount Sinai Hospital, 60 Murray Street (Box 32); ACDC Laboratory Floor 6, Room L6-201-1, Toronto, ON M5T 3L9, Canada. Phone: 416-586-8443; Fax: 416-619- 5521; E-mail: eleftherios.diamandis{at}sinaihealthsystem.ca
M. Music and M.A.J. Iafolla contributed equally to this article.
October 2019
Volume 18, Issue 10
Volume 18, Issue 10
Serum PD-1 Is Elevated after Pembrolizumab Treatment but Has No Predictive Value
Jump to section
Advertisement